45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
17,122
Insurances with rates
41
CPT / HCPCS codes
14,908
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 723700 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | $47,662 | $47,662 | $51.4 | $52.99 | 5 |
| 718142 | Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, aortic valve | $44,742 | $44,742 | $8,100 | $19,753 | 3 |
| 718141 | Percutaneous transcatheter closure of paravalvular leak; each additional occlusion device (List sepa | $44,742 | $44,742 | $11,702 | $11,949 | 3 |
| 705782 | Comprehensive electrophysiologic evaluation with transseptal catheterizations, insertion and reposit | $44,055 | $44,055 | $5,010 | $44,664 | 22 |
| 705421 | Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontra | $43,586 | $43,586 | $4,926 | $5,030 | 3 |
| 704850 | Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, foll | $40,900 | $40,900 | $4,969 | $5,074 | 3 |
| 705778 | Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode c | $38,312 | $38,312 | $5,010 | $44,664 | 22 |
| 705776 | Comprehensive electrophysiologic evaluation with insertion and repositioning of multiple electrode c | $38,312 | $38,312 | $5,010 | $44,664 | 22 |
| 720644 | Injection, sodium thiosulfate (hope), 100 mg | $34,251 | $34,251 | — | — | 3 |
| 681281 | Angiography, adrenal, bilateral, selective, radiological supervision and interpretation | $34,090 | $34,090 | — | — | 3 |
| 720492 | Injection, dostarlimab-gxly, 10 mg | $33,342 | $33,342 | $233 | $240 | 5 |
| 704849 | Computed tomography, abdomen and pelvis; with contrast material(s) | $32,060 | $32,060 | $913 | $1,404 | 3 |
| 704848 | Computed tomography, abdomen and pelvis; without contrast material | $31,255 | $31,255 | $913 | $1,404 | 3 |
| 719250 | Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutic | $30,530 | $30,530 | $913 | $1,404 | 3 |
| 721964 | Injection, eculizumab, 2 mg | $29,556 | $29,556 | $43.47 | $44.81 | 5 |
| 891624 | Osteogenesis stimulator, electrical, surgically implanted | $28,433 | $28,433 | $334 | $499 | 29 |
| 691800 | Computed tomography, heart, without contrast material, with quantitative evaluation of coronary calc | $27,984 | $27,984 | $913 | $13,040 | 9 |
| 719531 | Unlisted fluoroscopic procedure (eg, diagnostic, interventional) | $27,573 | $27,573 | — | — | 3 |
| 683443 | Transcranial Doppler study of the intracranial arteries; complete study UNSCHEDULED | $27,528 | $27,528 | $915 | $935 | 3 |
| 719249 | Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutic | $27,477 | $27,477 | $913 | $1,404 | 4 |
| 681543 | Adrenal imaging, cortex and/or medulla | $26,444 | $26,444 | — | — | 3 |
| 691870 | Injection, epirubicin hcl, 2 mg | $26,161 | $26,161 | $1.57 | $1.62 | 5 |
| 691558 | Injection, tenecteplase, 1 mg | $25,498 | $25,498 | $158 | $162 | 5 |
| 691798 | Computed tomographic angiography, heart, coronary arteries and bypass grafts (when present), with co | $25,441 | $25,441 | $2,160 | $2,205 | 3 |
| 691805 | Myocardial perfusion imaging, planar (including qualitative or quantitative wall motion, ejection fr | $24,119 | $24,119 | — | — | 3 |
| 691808 | Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or | $24,119 | $24,119 | — | — | 3 |
| 680078 | Computed tomography, soft tissue neck; without contrast material followed by contrast material(s) an | $23,944 | $23,944 | $913 | $1,404 | 3 |
| 680110 | Computed tomography, abdomen; without contrast material, followed by contrast material(s) and furthe | $23,221 | $23,221 | $7,956 | $8,123 | 3 |
| 682950 | Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if | $23,221 | $23,221 | $913 | $1,404 | 3 |
| 680088 | Computed tomography, thoracic spine; without contrast material, followed by contrast material(s) and | $23,221 | $23,221 | $1,422 | $1,452 | 3 |
| 682951 | Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if | $23,221 | $23,221 | $3,084 | $3,149 | 3 |
| 680091 | Computed tomography, lumbar spine; without contrast material, followed by contrast material(s) and f | $23,221 | $23,221 | $913 | $1,404 | 3 |
| 682974 | Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontr | $23,221 | $23,221 | $913 | $1,404 | 3 |
| 681686 | Cardiac blood pool imaging, gated equilibrium; multiple studies, wall motion study plus ejection fra | $22,885 | $22,885 | — | — | 3 |
| 696448 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | $22,130 | $22,130 | $1,620 | $1,670 | 5 |
| 683517 | Dilation of ureter(s) or urethra, radiological supervision and interpretation UNSCHEDULED | $21,634 | $21,634 | $1,329 | $1,357 | 3 |
| 691958 | Injection, pemetrexed, not otherwise specified, 10 mg | $21,623 | $21,623 | $3.66 | $3.77 | 5 |
| 719248 | Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutic | $21,527 | $21,527 | $913 | $1,404 | 3 |
| 682980 | Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, i | $21,524 | $21,524 | $3,165 | $3,231 | 3 |
| 683341 | Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, | $21,524 | $21,524 | $3,653 | $3,730 | 3 |
| 677851 | Computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, | $21,524 | $21,524 | $913 | $1,404 | 3 |
| 697860 | Injection, octreotide, depot form for intramuscular injection, 1 mg | $21,045 | $21,045 | $198 | $205 | 5 |
| 681723 | Kidney imaging morphology; with vascular flow and function, single study without pharmacological int | $20,492 | $20,492 | — | — | 3 |
| 688877 | Computed tomography guidance for stereotactic localization | $20,106 | $20,106 | $913 | $1,404 | 3 |
| 705772 | Thyroid imaging (including vascular flow, when performed); with single or multiple uptake(s) quantit | $20,092 | $20,092 | — | — | 3 |
| 680073 | Computed tomography, maxillofacial area; without contrast material, followed by contrast material(s) | $20,088 | $20,088 | $3,140 | $3,206 | 3 |
| 705884 | Parathyroid planar imaging (including subtraction, when performed); with tomographic (SPECT) | $19,604 | $19,604 | — | — | 3 |
| 719842 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | $19,254 | $19,254 | $19.38 | $19.98 | 5 |
| 679397 | Mechanical removal of pericatheter obstructive material (eg, fibrin sheath) from central venous devi | $18,698 | $18,698 | — | — | 3 |
| 691811 | Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or | $18,318 | $18,318 | $4,861 | $4,963 | 3 |
Showing top 50 of 17,122 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.